Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: A systematic review

Journal of Psychopharmacology

Volumn 24, Issue 4, 2010, Pages 513-520

  Whale, R ^a   Terao, T ^b   Cowen, P ^c   Freemantle, N ^d   Geddes, J ^c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b OITA UNIVERSITY   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Depressive disorder; Pindolol; SSRI; Systematic review

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; PINDOLOL; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

BIPOLAR DEPRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG POTENTIATION; GENETIC HETEROGENEITY; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG RESISTANCE; EVIDENCE-BASED MEDICINE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PATIENT DROPOUTS; PINDOLOL; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950419702     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108097714     Document Type: Review

References (31)

1. Artigas, F., Perez, V., Alvarez, E. (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248-251. (Pubitemid 24081512)
2. Ballesteros, J., Callado, LF (2004) Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J Affect Disord 79: 134-147. (Pubitemid 38340537)
3. Berman, RM, Darnell, AM, Miller, HL, Anand, A., Charney, DS (1997) Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 154: 37-43. (Pubitemid 27020190)
4. Berman, RM, Anand, A., Cappiello, A., Miller, HL, Hu, XS, Oren, DA, et al. (1999) The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol Psychiatry 45: 1170-1177. (Pubitemid 29236558)
5. Blier, P., de Montigny, C., Chaput, Y. (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 51 (Suppl.). 14-20. (Pubitemid 20134801)
6. Blier, P., de Montigny, C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220-226. (Pubitemid 24210726)
7. Blier, P., Bergeron, R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217-222.
8. Bordet, R., Thomas, P., Dupuis, B. (1998) Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Am J Psychiatry 155: 1346-1351. (Pubitemid 28471190)
9. de Montigny, C., Blier, P. (1984) Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies. Adv Biochem Psychopharmacol 39: 223-239.
10. DerSimonian, R., Laird, N. (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
11. Fernandes, E., Gomes, A., Costa, D., Lima, JL (2005) Pindolol is a potent scavenger of reactive nitrogen species. Life Sci 77: 1983-1992. (Pubitemid 41080641)
12. Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
13. Holland, C., Edwards, T., Hughes, S. (1997) A multi-centre, double-blind placebo-controlled study to investigate the effect of pindolol on the onset of antidepressant activity of paroxetine in the treatment of depression. Trial BRL 29060. SmithKline Beecham.
14. Kirsch, I., Moore, TJ, Scoboria, A., Nicholls, SS (2002) The emperors new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prev Treat 5: http://journals.apa.org/prevention/.
15. Maes, M., Libbrecht, I., Van Hunsel, F., Campens, D., Meltzer, HY (1999) Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. J Clin Psychopharmacol 19: 177-182. (Pubitemid 29161964)
16. McAskill, R., Mir, S., Taylor, D. (1998) Pindolol augmentation of antidepressant therapy. Br J Psychiatry 173: 203-208. (Pubitemid 28407451)
17. Perry, EB, Berman, RM, Sanacora, G., Anand, A., Lynch-Colonese, K., Charney, DS (2004) Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. J Clin Psychiatry 65: 238-243.
18. Perez, V., Gilaberte, I., Faries, D., Alvarez, E., Artigas, F. (1997) Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349: 1594-1597. (Pubitemid 27229140)
19. Perez, V., Soler, J., Puigdemont, D., Alvarez, E., Artigas, F. (1999) A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Arch Gen Psychiatry 56: 375-379. (Pubitemid 29165184)
20. Perez, V., Puiigdemont, D., Gilaberte, I., Alvarez, E., Artigas, F. ; Grup de Recerca en Trastorns Afectius (2001) Augmentation of fluoxetines antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. J Clin Psychopharmacol 21: 36-45. (Pubitemid 32096748)
21. Plenge, P., Mellerup, ET (2003) Pindolol and the acceleration of the antidepressant response. J Affect Disord 75: 285-289. (Pubitemid 36860032)
22. Rabiner, EA, Bhagwagar, Z., Gunn, RN, Sargent, PA, Bench, CJ, Cowen, PJ, et al. (2001) Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am J Psychiatry 158: 2080-2082. (Pubitemid 33104122)
23. Sackett, D. (1997) The Cochrane Collaboration Handbook. Oxford: The Cochrane Collaboration.
24. Segrave, R., Nathan, PJ (2005) Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. Hum Psychopharmacol 20: 163-174. (Pubitemid 40561850)
25. Sokolski, KN, Conney, JC, Brown, BJ, DeMet, EM (2004) Once-daily high-dose pindolol for SSRI-refractory depression. Psychiatry Res 125: 81-86.
26. Smeraldi, E., Zanardi, R., Benedetti, F., Di Bella, D., Perez, J., Catalano, M. (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3: 508-511. (Pubitemid 28515526)
27. Tome, MB, Isaac, MT, Harte, R., Holland, C. (1997) Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 12: 81-89. (Pubitemid 27286557)
28. Vinar, O., Vinarova, E., Horacek, J. (1996) Pindolol accelerates the therapeutic action of selective serotonin reuptake inhibitors (SSRI) in depression. Homeost Health Dis 37: 93-95. (Pubitemid 26148648)
29. Zanardi, R., Artigas, F., Franchini, L., Sforzini, L., Gasperini, M., Smeraldi, E., et al. (1997) How long should pindolol be associated with paroxetine to improve the antidepressant response. J Clin Psychopharmacol 17: 446-450. (Pubitemid 28389183)
30. Zanardi, R., Franchini, L., Gasperini, M., Lucca, A., Smeraldi, E., Perez, J. (1998) Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. J Clin Psychopharmacol 18: 441-446. (Pubitemid 28555326)
31. Zanardi, R., Serretti, A., Rossini, D., Franchini, L., Cusin, C., Lattuada, E., et al. (2001) Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry 50: 323-330. (Pubitemid 32816944)